Ten years from now, gastroenterology will be completely unrecognizable from what it is today. NextServices President Praveen Suthrum published the book Scope Forward, offering insights on the structural shift in gastroenterology, private equity investment, colon cancer screening alternatives and several trends affecting the specialty in 2020. Mr. Suthrum conducted more than 30 interviews for the book and presented opinions from a number of leading experts on topics affecting the specialty.
Author: Praveen Suthrum
Big tech companies launched several partnerships last year with providers of healthcare-specific products. Amazon, Google, Microsoft and Apple all played a role in the pandemic response while forwarding their strategies in digital health. Here are 20 moves they made in 2020. Amazon1. Amazon is rumored to be making plans to expand the Amazon Care program, which launched in September 2019, to other large employers. Amazon Care was initially available to just Amazon employees in Seattle and then expanded to all Amazon employees in Washington state. The program provides telemedicine and in-person primary healthcare services.
There are concerns that the COVID-19 pandemic has had a negative effect on cancer care but there is little direct evidence to quantify any effect. This study aims to investigate the impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England.
Mass screening identified a high prevalence of celiac disease among children, according to study results. Marisa G. Stahl, MD, of the department of pediatrics the University of Colorado Anschutz Medical Campus, and colleagues wrote that universal screening for celiac disease (CD) remains controversial in asymptomatic populations. Researchers are conducting the Autoimmunity Screening for Kids (ASK) study to screen children for CD, as well as type 1 diabetes.
In what most would agree has been a year fraught with difficulties, the Crohn’s & Colitis Foundation’s Greater New York Chapter turned its spotlight on a positive force of nature at its 2020 annual gala by honoring Ellen J. Scherl, MD, with the Rosenthal Humanitarian Award. “I am delighted to be a part of this great tradition,” Scherl, the Jill Roberts Professor of Inflammatory Bowel Disease at Weill Cornell Medicine, in New York City, said. Scherl, who established the IBD Center at NewYork-Presbyterian/Weill Cornell Medicine in 2002 and became the founding director of the Jill Roberts Center in 2006, is…
More evidence has emerged for fecal microbiota transplantation (FMT) as a safe option for treating recurrent Clostridioides difficile infection (CDI), according to a survey-based study. FMT was safe in both the short and long term with little risk of infection transmission, according to Sahil Khanna, MBBS, and colleagues, of the Mayo Clinic in Rochester, Minnesota.
Here are four updates from GI companies and practices over the past week: Investing firm Assured Healthcare Partners partnered with West Long Branch, N.J.-based Allied Digestive Health. Freenome’s novel multiomics blood test for colorectal cancer detected advanced adenomas with a 41 percent sensitivity at 90 percent specificity, according to results from its Ai-Emerge study. A developer is building a pair of medical office buildings in Leander, Texas, that could house an endoscopy center and gastroenterology clinic owned by Austin Gastroenterology.
In this episode of the AGA podcast Small Talk, Big Topics, sponsored by Medtronic, our hosts Drs. Nina Nandy and CS Tse are joined by guests Drs. Amrita Sethi and Mythili Pathipati. Amrita is the director of interventional endoscopy and president of Women in Endoscopy. Mythili is the co-founder of MGH House Staff Innovation Studio. Both are members of the AGA Center for GI Innovation and Technology. In this episode, the two guests take the time to share their knowledge on the importance of technology and innovation in the field of GI.
Haven, the healthcare joint venture created by Amazon, Berkshire Hathaway and JP Morgan to disrupt healthcare in the U.S., announced early last week that it will shut down by the end of February. As reported by Hugh Son of CNBC, “Many of the Boston-based firm’s 57 workers are expected to be placed at Amazon, Berkshire Hathaway or JP Morgan Chase as the firm’s individually push forward in their efforts, and the three companies are still expected to collaborate informally on healthcare-related projects.”